Fung Lam

406 total citations
8 papers, 300 citations indexed

About

Fung Lam is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Fung Lam has authored 8 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Fung Lam's work include Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and Cervical Cancer and HPV Research (2 papers). Fung Lam is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Response and Inflammation (2 papers) and Cervical Cancer and HPV Research (2 papers). Fung Lam collaborates with scholars based in United States and Canada. Fung Lam's co-authors include Vincent R. Bonagura, Bettie M. Steinberg, Allan L. Abramson, David Rosenthal, Lynda Hatam, James A. DeVoti, Blanka Kaplan, Mohd Israr, A. L. Abramson and Marc L. Gordon and has published in prestigious journals such as Clinical Cancer Research, Journal of Allergy and Clinical Immunology and Frontiers in Immunology.

In The Last Decade

Fung Lam

8 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fung Lam United States 5 162 113 98 50 37 8 300
Ennia Dametto Italy 9 86 0.5× 55 0.5× 30 0.3× 26 0.5× 81 2.2× 14 389
Ben X. Wang Canada 9 246 1.5× 61 0.5× 190 1.9× 53 1.1× 22 0.6× 33 511
Maura M. Bacchi Brazil 14 70 0.4× 93 0.8× 320 3.3× 28 0.6× 63 1.7× 28 472
Valentina Laquintana Italy 12 38 0.2× 71 0.6× 109 1.1× 21 0.4× 55 1.5× 15 349
Emilia Fernández‐López Spain 13 90 0.6× 129 1.1× 101 1.0× 43 0.9× 25 0.7× 44 444
Alice Gallagher United Kingdom 10 141 0.9× 97 0.9× 319 3.3× 64 1.3× 22 0.6× 15 478
Sergio Sánchez-Sosa Mexico 11 93 0.6× 55 0.5× 134 1.4× 41 0.8× 92 2.5× 22 422
Lesley Shield United Kingdom 12 172 1.1× 90 0.8× 377 3.8× 27 0.5× 17 0.5× 17 568
R. Alam United States 10 239 1.5× 164 1.5× 53 0.5× 100 2.0× 36 1.0× 16 503
Tsuyoshi Shirakawa Japan 11 72 0.4× 19 0.2× 171 1.7× 118 2.4× 76 2.1× 35 394

Countries citing papers authored by Fung Lam

Since Specialization
Citations

This map shows the geographic impact of Fung Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fung Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fung Lam more than expected).

Fields of papers citing papers by Fung Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fung Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fung Lam. The network helps show where Fung Lam may publish in the future.

Co-authorship network of co-authors of Fung Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Fung Lam. A scholar is included among the top collaborators of Fung Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fung Lam. Fung Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Gordon, Marc L., Erica Christen, Michelle N. Gong, et al.. (2024). An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer’s Disease. Journal of Alzheimer s Disease Reports. 8(1). 1111–1114. 2 indexed citations
2.
Israr, Mohd, Fung Lam, James A. DeVoti, et al.. (2023). PGE 2 expression by HPV6/11‐induced respiratory papillomas blocks NK cell activation in patients with recurrent respiratory papillomatosis. European Journal of Immunology. 53(4). e2250036–e2250036. 1 indexed citations
3.
DeVoti, James A., Mohd Israr, Fung Lam, et al.. (2022). Oropharyngeal tumor cells induce COX-2 expression in peripheral blood monocytes by secretion of IL-1α. Frontiers in Immunology. 13. 1011772–1011772. 3 indexed citations
4.
Israr, Mohd, James A. DeVoti, Fung Lam, et al.. (2020). Altered Monocyte and Langerhans Cell Innate Immunity in Patients With Recurrent Respiratory Papillomatosis (RRP). Frontiers in Immunology. 11. 336–336. 19 indexed citations
5.
Kaplan, Blanka, et al.. (2014). Rituximab and Immune Deficiency: Case Series and Review of the Literature. The Journal of Allergy and Clinical Immunology In Practice. 2(5). 594–600. 74 indexed citations
6.
Hatam, Lynda, James A. DeVoti, David Rosenthal, et al.. (2012). Immune Suppression in Premalignant Respiratory Papillomas: Enriched Functional CD4+Foxp3+ Regulatory T Cells and PD-1/PD-L1/L2 Expression. Clinical Cancer Research. 18(7). 1925–1935. 82 indexed citations
7.
Bonagura, Vincent R., Lynda Hatam, David Rosenthal, et al.. (2010). Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus‐6 and ‐11. Apmis. 118(6-7). 455–470. 113 indexed citations
8.
Hatam, Lynda, David Rosenthal, James A. DeVoti, et al.. (2008). CD4+Foxp3+CD127+low T-Regulatory Cells are Increased in HPV Infected Papillomas in Patients with Recurrent Respiratory Papillomatosis (RRP). Journal of Allergy and Clinical Immunology. 121(2). S211–S211. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026